2023-507354-32-00CompletedPhase 1
A Study to Learn How Different Amounts and Forms of the Study Intervention Called PF-07899895 are Tolerated and Act in the Body of Healthy Adults
Source: EU CTIS (euclinicaltrials.eu) · Last updated 27 Jun 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 55 (actual)
- First submitted
- 27 Sept 2023
- Start date
- 9 Sept 2024
- Lead sponsor
- Pfizer Inc.
- EU CT number
- 2023-507354-32-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 55
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pfizer Clinical Research Unit | Brussels | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.